Siegel RL, Giaquinto AN, Jemal A Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12-49.
Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392–404.
Google ScholarÂ
Ramachandran A, Snehalatha C. Rising burden of obesity in Asia. J Obes.2010; 2010:868573.
Google ScholarÂ
Bu L, Zhang Z, Chen J, Fan Y, Guo J, Su Y, et al. High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT. Gut. 2024;73:1156–68.
Google ScholarÂ
Andò S, Gelsomino L, Panza S, Giordano C, Bonofiglio D, Barone I, et al. Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms. Cancers. 2019;11:62.
Google ScholarÂ
Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Bustos M, MartÃnez JA, Moreno-Aliaga MJ. Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta. 2011;1807:664–78.
Google ScholarÂ
Zhang C, Wang XY, Zhang P, He TC, Han JH, Zhang R, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis. 2022;13:57.
Google ScholarÂ
Zhang H, Tian Y, Xu C, Chen M, Xiang Z, Gu L, et al. Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer. Cell Death Discov. 2025;11:78.
Google ScholarÂ
Czuba LC, Hillgren KM, Swaan PW. Post-translational modifications of transporters. Pharm Ther. 2018;192:88–99.
Google ScholarÂ
Resh MD. Fatty acylation of proteins: The long and the short of it. Prog Lipid Res. 2016;63:120–31.
Google ScholarÂ
Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K, et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat Commun. 2024;15:4642.
Google ScholarÂ
Chamberlain LH, Shipston MJ. The physiology of protein S-acylation. Physiol Rev. 2015;95:341–76.
Google ScholarÂ
S Mesquita F, Abrami L, Linder ME, Bamji SX, van der Dickinson BC. Mechanisms and functions of protein S-acylation. Nat Rev Mol Cell Biol. 2024;25:488–509.
Google ScholarÂ
Bu L, Wang H, Zhang S, Zhang Y, Liu M, Zhang Z, et al. Targeting APT2 improves MAVS palmitoylation and antiviral innate immunity. Mol Cell. 2024;84:3513–29.e3515.
Google ScholarÂ
Zhou L, Lian G, Zhou T, Cai Z, Yang S, Li W, et al. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. Nat Cancer. 2025;6:768–85.
Google ScholarÂ
Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, et al. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology. 2017;153:277–91.e219.
Google ScholarÂ
Xu C, Tian G, Jiang C, Xue H, Kuerbanjiang M, Sun L, et al. NPTX2 promotes colorectal cancer growth and liver metastasis by the activation of the canonical Wnt/β-catenin pathway via FZD6. Cell Death Dis. 2019;10:217.
Google ScholarÂ
Xu C, Gu L, Hu L, Jiang C, Li Q, Sun L, et al. FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer. Nat Commun. 2023;14:2042.
Google ScholarÂ
Duan Z, Yang M, Yang J, Wu Z, Zhu Y, Jia Q, et al. AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression. Cancer Lett. 2024;598:217130.
Google ScholarÂ
Wang G, Qin S, Chen L, Geng H, Zheng Y, Xia C, et al. Butyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling. Cell Death Dis. 2023;14:292.
Google ScholarÂ
Fujishita T, Kojima Y, Kajino-Sakamoto R, Mishiro-Sato E, Shimizu Y, Hosoda W, et al. The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells. Cancer Res. 2022;82:4179–90.
Google ScholarÂ
Wang S, Qiu J, Liu L, Su C, Qi L, Huang C, et al. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET. J Exp Clin Cancer Res. 2020;39:168.
Google ScholarÂ
Liu W, Zhang S, Li Q, Wu Y, Jia X, Feng W, et al. Lactate modulates iron metabolism by binding soluble adenylyl cyclase. Cell Metab. 2023;35:1597–612.e1596.
Google ScholarÂ
Guo R, Liu T, Shasaltaneh MD, Wang X, Imani S, Wen Q. Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy. Front Oncol. 2022;12:829212.
Google ScholarÂ
Zhan W, Li D, Che J, Zhang L, Yang B, Hu Y, et al. Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors. Eur J Med Chem. 2014;75:11–20.
Google ScholarÂ
He LF, Wang L, Li JW, Xiong X, Yue XL, Yuan PD, et al. Endothelial Gsα deficiency promotes ferroptosis and exacerbates atherosclerosis in apolipoprotein E-deficient mice via the inhibition of NRF2 signaling. Acta Pharm Sin. 2025;46:1289–302.
Google ScholarÂ
Hu J, Wang C, Huang X, Yi S, Pan S, Zhang Y, et al. Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling. Cell Rep. 2021;36:109726.
Google ScholarÂ
Zhang C, Xu Y, Zhu X, Zhang X, Wang F, Hu L, et al. Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer. Oncogene. 2024;43:1985–99.
Google ScholarÂ
Zhang Q, Du Z, Zhou W, Li W, Yang Q, Yu H, et al. ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation. Cancer Gene Ther. 2024;31:1427–37.
Google ScholarÂ
Hu G, Yao H, Wei Z, Li L, Yu Z, Li J, et al. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. Sci Rep. 2023;13:12403.
Google ScholarÂ
Yao F, Zhou S, Zhang R, Chen Y, Huang W, Yu K, et al. CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma. Cancer Lett. 2024;593:216935.
Google ScholarÂ
Li W, Liu J, Yu T, Lu F, Miao Q, Meng X, et al. ZDHHC9-mediated Bip/GRP78 S-palmitoylation inhibits unfolded protein response and promotes bladder cancer progression. Cancer Lett. 2024;598:217118.
Google ScholarÂ
Chen L, Xing X, Zhu Y, Chen Y, Pei H, Song Q, et al. Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. Cancer Lett. 2024;587:216696.
Google ScholarÂ
Lin Z, Huang K, Guo H, Jia M, Sun Q, Chen X, et al. Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. Biomed Pharmacother. 2023;161:114567.
Google ScholarÂ
Wei F, Wang Y, Yao J, Mei L, Huang X, Kong H, et al. ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy. 2024;20:2719–37.
Google ScholarÂ
Yang YM, Ma HB, Xiong Y, Wu Q, Gao XK. PEX11B palmitoylation couples peroxisomal dysfunction with Schwann cells fail in diabetic neuropathy. J Biomed Sci. 2025;32:20.
Google ScholarÂ
Cao H, Li Y, Liu S, Gao H, Zhu C, Li L, et al. The role of S-palmitoylation of C4BPA in regulating murine sperm motility and complement resistance. Int J Biol Macromol. 2024;281:136196.
Google ScholarÂ
Tang J, Peng W, Feng Y, Le X, Wang K, Xiang Q, et al. Cancer cells escape p53’s tumor suppression through ablation of ZDHHC1-mediated p53 palmitoylation. Oncogene. 2021;40:5416–26.
Google ScholarÂ
Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharm Ther. 2020;206:107447.
Google ScholarÂ
Yang C, Song J, Hwang S, Choi J, Song G, Lim W. Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells. Redox Biol. 2021;47:102144.
Google ScholarÂ
Zhou M, Huang Z, Ma Z, Chen J, Lin S, Yang X, et al. The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy. Cancer Drug Resist. 2025;8:34.
Google ScholarÂ
Xu R, Du A, Deng X, Du W, Zhang K, Li J, et al. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. J Exp Clin Cancer Res. 2024;43:230.
Google ScholarÂ
Li X, Wang J, Lin W, Yuan Q, Lu Y, Wang H, et al. circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop. Mol Cancer. 2022;21:135.
Google ScholarÂ
Su J, Wang J, Chen W, Xu Y, Yang W, Liu W, et al. Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer. Cancer Drug Resist. 2025;8:22.
Google ScholarÂ
Zhao Y, Hamza MS, Leong HS, Lim CB, Pan YF, Cheung E, et al. Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells. Oncogene. 2008;27:1–8.
Google ScholarÂ
Luo Y, Chen C. The roles and regulation of the KLF5 transcription factor in cancers. Cancer Sci. 2021;112:2097–117.
Google ScholarÂ
Okechukwu CC, Gmeiner WH. CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis. Cancer Drug Resist. 2025;8:35.
Google ScholarÂ
Stubbs NM, Roady TJ, Schwermann MP, Eteshola EO, MacDonald WJ, Purcell C, et al. Acquired resistance to molecularly targeted therapies for cancer. Cancer Drug Resist. 2025;8:27.
Google ScholarÂ
Hansen AL, Mukai K, Schopfer FJ, Taguchi T, Holm CK. STING palmitoylation as a therapeutic target. Cell Mol Immunol. 2019;16:236–41.
Google ScholarÂ
Qian YR, Zhao YJ, Zhang F. Protein palmitoylation: biological functions, disease, and therapeutic targets. MedComm. 2025;6:e70096.
Google ScholarÂ
He Q, Qu M, Shen T, Su J, Xu Y, Xu C, et al. Control of mitochondria-associated endoplasmic reticulum membranes by protein S-palmitoylation: Novel therapeutic targets for neurodegenerative diseases. Ageing Res Rev. 2023;87:101920.
Google ScholarÂ
Zhang M, Zhou L, Xu Y, Yang M, Xu Y, Komaniecki GP, et al. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature. 2020;586:434–9.
Google ScholarÂ
Mo Y, Han Y, Chen Y, Fu C, Li Q, Liu Z, et al. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol Cancer. 2024;23:274.
Google ScholarÂ
Fuller W. zDHHC9 and the Control of Natriuretic Peptide Secretion by the Heart. JACC Basic Transl Sci. 2023;8:543–5.
Google ScholarÂ
Essandoh K, Subramani A, Ferro OA, Teuber JP, Koripella S, Brody MJ. zDHHC9 Regulates Cardiomyocyte Rab3a Activity and Atrial Natriuretic Peptide Secretion Through Palmitoylation of Rab3gap1. JACC Basic Transl Sci. 2023;8:518–42.
Google ScholarÂ
Zeng L, Zhu Y, Moreno CS, Wan Y. New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy. Semin Cancer Biol. 2023;90:29–44.
Google ScholarÂ
Li J, Liu L, Zhou WQ, Cai L, Xu ZG, Rane MJ. Roles of Krüppel-like factor 5 in kidney disease. J Cell Mol Med. 2021;25:2342–55.
Google ScholarÂ
Wu Q, Liu Z, Gao Z, Luo Y, Li F, Yang C, et al. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8( + ) T-cell-dependent antitumor immunity. Theranostics. 2023;13:1381–400.
Google ScholarÂ
Kyriazis ID, Hoffman M, Gaignebet L, Lucchese AM, Markopoulou E, Palioura D, et al. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy. Circ Res. 2021;128:335–57.
Google ScholarÂ
Wu Y, Chen S, Shao Y, Su Y, Li Q, Wu J, et al. KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer. Adv Sci. 2023;10:e2304638.
Google ScholarÂ
Methatham T, Nagai R, Aizawa K A New Hypothetical Concept in Metabolic Understanding of Cardiac Fibrosis: Glycolysis Combined with TGF-β and KLF5 Signaling. Int J Mol Sci. 2022;23.
Yusefi M, Lee-Kiun MS, Shameli K, Teow SY, Ali RR, Siew KK, et al. 5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment. Carbohydr Polym. 2021;273:118523.
Google ScholarÂ
Smabers LP, Wensink E, Verissimo CS, Koedoot E, Pitsa KC, Huismans MA, et al. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response. J Exp Clin Cancer Res. 2024;43:61.
Google ScholarÂ
Yang L, Yang J, Kleppe A, Danielsen HE, Kerr DJ. Personalizing adjuvant therapy for patients with colorectal cancer. Nat Rev Clin Oncol. 2024;21:67–79.
Google ScholarÂ

